A: Nutrilive® is an intravenous nutrition supplement containing essential amino acids that help in protein synthesis. It is primarily used for patients who are unable to meet their protein requirements through oral intake due to medical conditions. Nutrilive® is beneficial for individuals suffering from malnutrition, gastrointestinal disorders causing reduced protein absorption, chronic or acute infections, renal and hepatic insufficiency, and conditions like cancer, where maintaining proper nutrition is crucial. Additionally, it is particularly helpful in cases of massive protein loss due to burns, fractures, wounds, or surgery. Patients with high metabolic stress or starvation-related malnutrition can also benefit from Nutrilive® as it aids in faster recovery and ensures adequate protein supply for essential bodily functions.

A: Nutrilive® is administered intravenously and should always be given under the supervision of a healthcare professional. The dosage depends on the patient’s nutritional status, metabolic needs, and degree of stress on the body. For adults, the nitrogen requirement varies based on their condition: 0.10-0.15g nitrogen/kg/day for those with minor metabolic stress, 0.15-0.20g nitrogen/kg/day for moderate stress, and up to 0.20-0.25g nitrogen/kg/day for patients experiencing severe conditions like burns or sepsis. This translates to an infusion rate of 15-35 ml/kg/day, with a total volume of 1,000-2,000 ml per day. For children and infants, a gradual increase in the infusion rate is recommended, starting with 28-35 ml/kg body weight per day. It is crucial to administer Nutrilive® slowly at 2-4 ml per minute (30-60 drops per minute) to avoid complications. Patients with obesity should have their dosage calculated based on their ideal weight to prevent overnutrition.

A: Nutrilive® is generally well tolerated; however, in rare cases, some patients may experience side effects such as nausea, vomiting, flushing, and sweating when the infusion rate exceeds the recommended limit. Hypersensitivity reactions, though uncommon, have been reported, and patients should be monitored for signs of allergic reactions like rash, itching, or difficulty breathing. As with all hypertonic solutions, there is a risk of thrombophlebitis (vein inflammation) if peripheral veins are used. To minimize this risk, Nutrilive® can be co-administered with a 10% fat emulsion. For severely ill premature infants, monitoring for hyperphenylalaninemia (elevated phenylalanine levels) is recommended, as they may have difficulty metabolizing certain amino acids. Patients must also ensure that the solution is clear and free of particles before use. If any adverse reactions occur, infusion should be immediately discontinued, and a healthcare professional should be consulted.

A: Nutrilive® can be administered during pregnancy if deemed necessary by a healthcare provider. Studies have reported the successful and safe use of amino acid solutions in pregnant women, but like any medical treatment, it should only be used when clearly needed and under medical supervision. During lactation, Nutrilive® is also considered safe, as amino acids are essential nutrients required by both the mother and baby. In terms of drug interactions, Nutrilive® does not have pharmacological effects at the recommended dosage, meaning it is not expected to interfere with other medications. However, patients should always inform their doctor if they are taking any other medications, as this helps prevent potential complications. Additionally, Nutrilive® should not be mixed with other intravenous preparations due to the risk of microbial contamination or incompatibility with other solutions.

A: Nutrilive® should be stored in a cool, dry place at a temperature between 15°C to 25°C, away from direct light and heat sources. Freezing should be avoided, as it may affect the stability of the solution. Before administration, always check that the solution is clear and that the packaging is intact. If the solution appears turbid or contains particles, it should not be used, and any unused portion should be discarded immediately. Overdosing on Nutrilive® is rare, but in cases where excessive amounts are administered, patients may experience metabolic imbalances, fluid overload, or hyperphenylalaninemia. If overdose symptoms occur, the infusion should be stopped, and medical attention should be sought immediately to manage any complications effectively. To prevent overdosing, Nutrilive® should always be administered under strict medical supervision, with close monitoring of fluid balance, electrolytes, and amino acid levels in the body.